RxSight Vs. ePlus Industry Stock Comparison

Sell

6

RXST
RxSight

Last Price:

44.19

Seasonality Move:

35.42%

Sell

27

PLUS
ePlus

Last Price:

80.50

Seasonality Move:

20.86%

Sell

6

RxSight (RXST) is a Sell

Is RxSight a Buy, Sell or Hold?

The current RxSight [RXST] share price is $44.65. The Score for RXST is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
RXST is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Sell

27

ePlus (PLUS) is a Sell

Is ePlus a Buy, Sell or Hold?

The current ePlus [PLUS] share price is $80.03. The Score for PLUS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
PLUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RXST Stock Price Chart

What is RxSight's stock price today?

The RxSight share price today is $44.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXST is experiencing slight selling pressure.

PLUS Stock Price Chart

What is ePlus's stock price today?

The ePlus share price today is $80.03
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLUS is experiencing selling pressure, which indicates risk of future bearish movement.

RXST Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.95	Sell
Relative Strength Index (14 RSI):	33.75	Sell
Chaikin Money Flow:	-198994	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(47.85 - 51.99)	Sell
Bollinger Bands (100):	(47.12 - 54.96)	Sell

PLUS Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.37	Sell
Relative Strength Index (14 RSI):	28.12	Sell
Chaikin Money Flow:	-371573	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(91.15 - 100.85)	Sell
Bollinger Bands (100):	(81.19 - 98.29)	Sell

RXST Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	49.12	Sell
20-day SMA:	49.93	Sell
50-day SMA:	50.74	Sell
200-day SMA:	52.84	Sell
8-day EMA:	47.91	Sell
20-day EMA:	49.34	Sell
50-day EMA:	50.34	Sell
200-day EMA:	49.06	Sell

PLUS Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	93.25	Sell
20-day SMA:	94.97	Sell
50-day SMA:	95.27	Sell
200-day SMA:	83.59	Sell
8-day EMA:	92.26	Sell
20-day EMA:	94.28	Sell
50-day EMA:	94.05	Sell
200-day EMA:	84.44	Sell

RxSight Earnings Growth & RXST Earnings Dates

Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.96 per share, and an increase next year of $0.29 per share.

ePlus Earnings Growth & PLUS Earnings Dates

Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.53 per share, and a decrease next year of $0.07 per share.

RxSight Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ePlus Technical Analysis

	Oct 31	Nov 1	Nov 4	Nov 5	Nov 6	Nov 7	Nov 8	Nov 11	Nov 12	Nov 13
	Oct		Nov
	31	01	04	05	06	07	08	11	12	13
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):